Prelude Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $279K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $71.7K | Sell |
|
|||||
|
2023
Q2 | $213K | Sell |
|
|||||
|
2023
Q1 | $313K | Buy |
|
|||||
|
2022
Q4 | $173K | Sell |
|
|||||
|
2022
Q3 | $732K | Buy |
|
|||||
|
2022
Q2 | $762K | Sell |
|
|||||
|
2022
Q1 | $2.02M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $221K | Sell |
|
|||||
|
2021
Q2 | $321K | Sell |
|
|||||
|
2021
Q1 | $841K | Buy |
|
|||||
|
2020
Q4 | $302K | Buy |
|
|||||
|
2020
Q3 | $66K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $4K | Buy |
|